Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population

Martin, Alexandra; Rief, Winfried; Klaiberg, Antje; Bräehler, Elmar

doi:10.1016/j.genhosppsych.2005.07.003

Cited by 1,153 publications

(848 citation statements)

References 22 publications

Supporting

Mentioning

799

Contrasting

Unclassified

Order By: Relevance

“…In our data, an association with a higher number of somatic comorbidities was found in men, but not in women suggesting that physical and mental health may be more closely aligned in men than women and highlight the importance of sex-specific analyses. Our analyses showed an inverse associations of all three measures with physical and social functioning, confirming previous associations between SF-36 scales and CIDI-MDD (Wittchen et al, 2000a) in the general population as well as with PHQ-9 measures (Martin et al, 2006). In relation to sick leave and health service utilization, we found strong associations between the number of sick leave days in the past 12 months and all three measures.…”

Section: Health-related Correlatessupporting

confidence: 89%

Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany

Maske

Buttery

Beesdo‐Baum

et al. 2016

Journal of Affective Disorders

View full text Add to dashboard Cite

show abstract

Section: Health-related Correlatessupporting

confidence: 89%

Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany

Maske

Buttery

Beesdo‐Baum

et al. 2016

Journal of Affective Disorders

View full text Add to dashboard Cite

show abstract

“…Persons with a total depression severity score of X10 were defined as having current depression. The PHQ-8 has been shown to provide valid measurements on major depression in the general population similar to that of the PHQ-9, [33][34][35][36] and the scoring of X10 has a sensitivity and specificity of 88% for major depression. 34 Lifetime diagnosed depression and anxiety were assessed by asking respondents whether they had ever been told by a doctor or other healthcare provider that they had a depressive disorder (including depression, major or minor depression, or dysthymia) or an anxiety disorder (including acute or post-traumatic stress disorder, anxiety, generalized anxiety disorder, obsessive-compulsive disorder, panic disorder, phobia or social anxiety disorder).…”

Section: Methodsmentioning

confidence: 95%

Depression and anxiety among US adults: associations with body mass index

et al. 2009

View full text Add to dashboard Cite

Background: Obesity is associated with an increased risk of developing a variety of chronic diseases, most of which are associated with psychiatric disorders. We examined the associations of depression and anxiety with body mass index (BMI) after taking into consideration the obesity-related comorbidities (ORCs) and other psychosocial or lifestyle factors. Methods: We analyzed the data collected from 177 047 participants (agedX18 years) in the 2006 Behavioral Risk Factor Surveillance System. Current depression was assessed by the Patient Health Questionnaire-8 diagnostic algorithm. Lifetime diagnoses of depression, anxiety and ORCs were self-reported. The prevalence of the three psychiatric disorders was age standardized to the 2000 US population. Multivariate-adjusted prevalence ratios were computed to test associations of depression and anxiety with BMI using SUDAAN software. Results: The age-adjusted prevalence of current depression, lifetime diagnosed depression and anxiety varied significantly by gender. Within each gender, the prevalence of the three psychiatric disorders was significantly higher in both men and women who were underweight (BMIo18.5 kg/m 2 ), in women who were overweight (BMI: 25-o30 kg/m 2 ) or obese (BMIX30 kg/m 2 ), and in men who had class III obesity (BMIX40 kg/m 2 ) than in those with a normal BMI (18.5Ào25 kg/m 2 ). After adjusting for demographics, ORCs, lifestyle or psychosocial factors, compared with men with a normal BMI, men with a BMIX40 kg/m 2 were significantly more likely to have current depression or lifetime diagnosed depression and anxiety; men with a BMIo18.5 kg/m 2 were also significantly more likely to have lifetime diagnosed depression. Women who were either overweight or obese were significantly more likely than women with a normal BMI to have all the three psychiatric disorders.Conclusions: Our results demonstrate that disparities in the prevalence of depression and anxiety exist among people with different BMI levels independent of their disease status or other psychosocial or lifestyle factors.

show abstract

“…The Short Form 36 (SF36), a validated generic instrument that measures quality of life, provided information on the patient's physical and mental health status [14]. Depression was assessed using the nine items of the validated Patient Health Questionnaire 9 (PHQ-9) [15]. Anxiety was measured by means of the anxiety subscale of the validated Dutch version of the Brief Symptom Inventory, consisting of six items [16].…”

Section: Assessment Of Possible Determinantsmentioning

confidence: 99%

Determinants of methotrexate adherence in rheumatoid arthritis patients

et al. 2016

View full text Add to dashboard Cite

In rheumatoid arthritis (RA) patients, weekly intake of methotrexate (MTX) is the basic drug treatment. This observational study aims to investigate how many RA patients are adherent in terms of MTX intake and to identify determinants of non-adherence. Intake of MTX (orally or via injection) was recorded in 129 RA patients with an electronic monitoring system (MEMS ® ) during 16 weeks. In addition, two adherence questionnaires, the Medication Adherence Report Scale (MARS-5) and the Compliance-Questionnaire-Rheumatology (CQR) as well as a visual analogue scale (VAS) measuring MTX adherence, were administered to these patients. As possible determinants of adherence, data on demographics, disease and treatment characteristics, depression, illness cognitions, motivation, and social support were collected. Of all participants, 58 % were fully adherent and 75 % skipped at most one dose during 16 weeks. A better mental health status and suffering from comorbidities had a positive effect on adherence, while living alone had a negative effect. These three predictors explained 30 % of the variance in MTX adherence. Of the three self-report medication adherence measures, the VAS correlated the highest with the results of the electronic monitoring system (r = 0.552, p = 0.01). A relatively high adherence rate was observed in RA patients treated with MTX. The determinants identified by this study could be used to screen patients at risk for non-adherence. A simple VAS scale seems to be an acceptable way for a preliminary screening of MTX adherence.

show abstract

Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population

Cited by 1,153 publications

References 22 publications

Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany

Prevalence and correlates of DSM-IV-TR major depressive disorder, self-reported diagnosed depression and current depressive symptoms among adults in Germany

Depression and anxiety among US adults: associations with body mass index

Determinants of methotrexate adherence in rheumatoid arthritis patients

Contact Info

Product

Resources

About